Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Vladimir Melnichenko"'
Autor:
Tatiana Nikitina, Ekena Andreevskaya, Elena Babich, Natalia Bulieva, Olga Vinogradova, Elena Volodicheva, Sergey Voloshin, Natalia Glonina, Sergey Dubov, Natalya Esefieva, Elena Zinina, Maria Ivanova, Tatyana Klitochenko, Anna Kopylova, Alexander Kulagin, Galina Kuchma, Olga LI, Elza Lomaia, Anna Lyamkina, Anait Melikyan, Vladimir Melnichenko, Svetlana Menshakova, Natalia Minaeva, Tatiana Mitina, Elena Morozova, Oksana Ochirova, Alexey Polyakov, Tatiana Pospelova, Andrey Proydakov, Oleg Rukavitsyn, Guzel’ Safuanova, Irina Soubortseva, Mikhail Fominykh, Maria Frolova, Tatiana Shelekhova, Dmitriy Sherstnev, Tatiana Shneider, Vasiliy Shuvaev, Natalia Porfirieva, Esther Oliva, Sam Salek, Tatyana Ionova
Publikováno v:
HemaSphere, Vol 7, p e23759a8 (2023)
Externí odkaz:
https://doaj.org/article/09046401ce7f4663970b72acf4a23c8b
Autor:
Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Maria Fogliatto, Alejandro Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Herve Ghesquieres, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Publikováno v:
Blood Journal.
Previous analyses of the phase 2 KEYNOTE-170 (NCT02576990) study demonstrated effective antitumor activity and acceptable safety of pembrolizumab 200 mg given every 3 weeks for up to 35 cycles (~2 years) in patients with relapsed/refractory (R/R) pri
Autor:
Jasmine Zain, Robert Orlowski, Philippe Armand, Guilherme Fleury Perini, Arun Balakumaran, Jakub Svoboda, Jing Ouyang, Pier Luigi Zinzani, Pei-Hsuan Chen, Vincent Ribrag, Catherine Thieblemont, Vladimir Melnichenko, Gayane Tumyan, Azra H. Ligon, Gilles Salles, Margaret A. Shipp, Maria D Caballero, Muhit Ozcan, Beth Christian, Zafer Gulbas, Donna Neuberg, Jan Walewski, Robert A. Redd, Arkendu Chatterjee, Sanjay R. Patel, Sergio Portino, Scott J. Rodig, Kamal Bouabdallah, Laura Fogliatto
Publikováno v:
Journal of Clinical Oncology
Ann Transl Med
Ann Transl Med
PURPOSE Patients with relapsed or refractory primary mediastinal large B-cell lymphoma (rrPMBCL) have a poor prognosis, and their treatment represents an urgent and unmet need. Because PMBCL is associated with genetic aberrations at 9p24 and overexpr
Autor:
Iara Goncalves, Neta Goldschmidt, Jose de Oliveira, Naohiro Sekiguchi, Laura Fogliatto, Robin Gasiorowski, Pier Luigi Zinzani, John Kuruvilla, Vladimir Melnichenko, Nathalie A. Johnson, Armando Santoro, Ying Zhu, Ewa Paszkiewicz-Kozik, Patricia Marinello, Radhakrishnan Ramchandren, Iryna Kryachok, Valeria Buccheri, Akash Nahar, Sergey Alekseev, Guilherme Fleury Perini
Publikováno v:
Web of Science
8005 Background: PD-1 blockade via pembro monotherapy showed antitumor activity in R/R cHL. KEYNOTE-204 (NCT02684292) was a randomized, international, open-label, phase III study of pembro vs BV in R/R cHL. Methods: Patients (pts) were aged ≥18 y,
Autor:
Arun Balakumaran, Azra H. Ligon, Catherine Thieblemont, Donna Neuberg, Robert Orlowski, Gilles Salles, Jakub Svoboda, Krimo Bouabdallah, Pier Luigi Zinzani, Vladimir Melnichenko, Vincent Ribrag, Muhit Ozcan, Jan Walewski, Dolores Caballero, Arkendu Chatterjee, Guilherme Fleury Perini, Laura Fogliatto, Gayane Tumyan, Sanjay S. Patel, Jasmine Zain, Jing Ouyang, Sergio Portino, Margaret A. Shipp, Robert A. Redd, Pei-Hsuan Chen, Beth Christian, Scott J. Rodig, Zafer Gulbas, Philippe Armand
Publikováno v:
Blood. 132:228-228
Introduction: Patients (pts) with relapsed/refractory PMBCL (rrPMBCL) are typically treated like those with diffuse large B cell lymphoma (DLBCL), often with limited effective treatment options and poor outcomes. Unlike DLBCL and similar to classical
Autor:
Vladimir Melnichenko, Elena Volodicheva, Andrey Zaritskey, Elena Shukaeva, T S Kaporskaya, Elena Kirillova, Andrey Proydakov, Tat'yana Evgen'evna Byalik, Andrey V. Gubkin, Yulia Virts, Natalya Ilyina, Andrey M. Rumyantsev, TS Nikulina, Natalya N. Glonina, Sergey Shklyaev, Lyubov Anchukova, Olga Samoilova, Oleg Rukavitsyn, Igor Davidkin, Renat Badaev, Tatyana Sycheva, Oksana Ochirova, Natalya Esefeva, Olga Vasilyeva, Tatyana Ksenzova, Tatyana Silina, Irina Chebykina, Yulia Mirolubova, Galina Kuchma, Vera A. Zherebtsova, K. D. Kaplanov, Yulia Bogdanova, Irina Lysenko, Natalya Bulieva, EA Stadnik, Vladimir Strugov
Publikováno v:
Publons
ResearcherID
ResearcherID
CLL is the disease of the elderly. Many CLL pts have high comorbidity burden, which makes them ineligible for intensive chemotherapy regimens like FCR. Recently, DCLLSG CLL10 trial proved comparable efficacy of BR and FCR regimens, but better tolerab
Autor:
Yury L. Shevchenko, Inna V. Vereschagina, Vladimir Melnichenko, Andrei D. Kulagin, Gennady N. Bisaga, Gary I. Gorodokin, Boris V. Afanasiev, Yury N. Fedotov, Anton V. Kishtovich, Andrei A. Novik, Tatiana I. Ionova, Igor A. Lisukov, Denis A. Fedorenko, Olga A. Malysheva, Sergei Voloshin
Publikováno v:
Blood. 106:5467-5467
HDCT+ASCT is a new and promising therapy for MS patients. Among a number of unclear questions is the terms of conducting HDCT+ASCT. According to our concept there are 3 strategies of HDCT+ASCT depending on the terms of disease process: early, convent
Autor:
Yury L. Shevchenko, Roman Ivanov, Alexey N. Kuznetcov, Vladimir Melnichenko, Anton V. Kishtovich, Andrei A. Novik, Gary J Gorodokin, Alexandr A. Myasnikov, Igor A. Lisukov, Denis A. Fedorenko, Oleg A. Rykavicin, Boris A. Afanasiev, Tatyana Ionova
Publikováno v:
Publons
During the last decade immunoablative therapy with ASCT (IT+ASCT) has been used with increasing frequency as a therapeutic option for MS patients. Among a number of unanswered questions is the timing of IT+ASCT. We have identified 3 strategies of IT+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9deb2aa1a820f0d89326440175bb92b
https://publons.com/publon/21786756/
https://publons.com/publon/21786756/
Autor:
Gorodokin, G., Kurbatova, K. A., Kruglina, R. V., Ionova, T. I., Fedorenko, D. A., Vladimir Melnichenko, Kitaev, V. M., Kuznetsov, A. N., Novik, A. A.
Publikováno v:
Publons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::443c37d07ee648a75c1cf1fc2b6410d4
https://publons.com/publon/21786734/
https://publons.com/publon/21786734/
Autor:
Kishtovich, A., Chelombit, L., Bisaga, G., Vladimir Melnichenko, Malysheva, O., Kulagin, A., Lesukov, I., Ionova, T., Novik, A., Shevchenko, Y.
Publikováno v:
Web of Science
Publons
Publons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3872fee4e242e77bb984baf8429d0e9b
https://publons.com/wos-op/publon/21786759/
https://publons.com/wos-op/publon/21786759/